当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3551346
自主品牌
已选条件
-
T9789Cevidoplenib dimesylate hydrochlorideCevidoplenib dimesylate hydrochloride
Cevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.
价 格：￥电议型 号：T9789产 地：中国大陆
-
T6047Ralimetinib dimesylateRalimetinib Mesylate；LY2228820 dimesylate；Ralimetinib；LY2228820
Ralimetinib Mesylate is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
价 格：￥电议型 号：T6047产 地：中国大陆
-
T2429Olverembatinib dimesylateHQP1351；GZD824 Dimesylate
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I).
价 格：￥电议型 号：T2429产 地：中国大陆
-
T10433Osimertinib dimesylate奥希替尼二甲磺酸盐；AZD-9291 (dimesylate)；Mereletinib (dimesylate)
Osimertinib dimesylate is an irreversible and mutant selective EGFR inhibitor (IC50s: 12 and 1 nM against EGFR L858R and EGFR L858R/T790M).
价 格：￥电议型 号：T10433产 地：中国大陆
-
T10433Osimertinib dimesylateOsimertinib dimesylate,AZD-9291 (dimesylate),Mereletinib (dimesylate)
Osimertinib dimesylate is an irreversible and mutant selective EGFR inhibitor (IC50s: 12 and 1 nM against EGFR L858R and EGFR L858R/T790M).
价 格：￥电议型 号：T10433产 地：美洲
-
T2429GZD824 DimesylateGZD824 Dimesylate,HQP1351,
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I).
价 格：￥电议型 号：T2429产 地：美洲
-
T6047Ralimetinib MesylateRalimetinib Mesylate,LY2228820 dimesylate,LY2228820
Ralimetinib Mesylate is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
价 格：￥电议型 号：T6047产 地：美洲
-
T6978Almitrine mesylate；甲磺酸阿米三嗪Almitrine dimesylate|||Almitrine bismethanesulfonate|||Almitrine bismesyla
Almitrine mesylate (Almitrine dimesylate) inhibits selectively the Ca2+-dependent K+ channel and that in rat chemoreceptor cells,used in the treatment of hypoxemic chronic lung diseases.
价 格：￥电议型 号：T6978产 地：中国大陆
-
T6287LTariquidar dimesylate；化合物 T6287LD 06008|||XR9576|||D06008|||XR 9576|||Tariquidar dimesilate|||XR-957
Tariquidar is a P-glycoprotein inhibitor undergoing research as an adjuvant against multidrug resistance in cancer. Tariquidar non-competitively binds to the p-glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs.
价 格：￥电议型 号：T6287L产 地：中国大陆
-
T6047Ralimetinib dimesylate；化合物Ralimetinib MesylateLY2228820 dimesylate|||Ralimetinib|||LY2228820|||Ralim
Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
价 格：￥电议型 号：T6047产 地：中国大陆
-
T38620Prexasertib dimesylate；Prexasertib dimesylateLY2606368 dimesylate；LY2606368 dimesylate
Prexasertib dimesylate (LY2606368 dimesylate) is a highly selective ATP-competitive second-generation inhibitor of checkpoint kinase 1 (CHK1). With a K i of 0.9 nM and an IC 50 of <1 nM, Prexasertib dimesylate effectively inhibits CHK2 (IC 50 = 8 nM) and RSK1 (IC 50 = 9 nM). Its mechanism of action involves inducing double-stranded DNA breakage and replication catastrophe, ultimately leading to apoptosis. Moreover, Prexasertib dimesylate demonstrates potent anti-tumor activity.
价 格：￥电议型 号：T38620产 地：中国大陆
-
T28355Pentamidine dimesylate；化合物 T28355Pentamidine dimesylate
Pentamidine dimesylate is an inhibitor of calcium-dependent complex formation with p53 [(Ca)S100B-p53) in malignant melanoma (MM). Pentamidine dimesylate restores p53 tumor suppressor activity in vivo.
价 格：￥电议型 号：T28355产 地：中国大陆
-
T2429Olverembatinib dimesylate；化合物GZD824 DimesylateGZD824 Dimesylate|||HQP1351；GZD824 Dimesylate|||HQP135
Olverembatinib dimesylate (GZD824 Dimesylate) is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I).
价 格：￥电议型 号：T2429产 地：中国大陆
-
T11647INCB 3284 dimesylate；化合物 T11647INCB 3284 dimesylate
INCB 3284 dimesylate is a selective and orally bioavailable human CCR2 antagonist, inhibiting monocyte chemoattractant protein-1 binding to hCCR2 (IC50: 3.7 nM). It can be used in the research of acute liver failure.
价 格：￥电议型 号：T11647产 地：中国大陆
-
T10433Osimertinib dimesylate奥希替尼二甲磺酸盐奥希替尼二甲磺酸盐|||Mereletinib (dimesylate)|||AZD-9291 (dimesylate)
Osimertinib dimesylate is an irreversible and mutant selective EGFR inhibitor (IC50s: 12 and 1 nM against EGFR L858R and EGFR L858R/T790M).
价 格：￥电议型 号：T10433产 地：中国大陆
